semaglutide distributors Market Size, Share & Trends Report, 2025-2035 Early uptake of Wegovy pill

Eli Lilly (LLY) stands as a titan in the GLP-1 space, with its stock currently trading at $983.26 and boasting a colossal market cap of $927.57 billion

Patients should also be aware of rare but serious risks including pancreatitis, gallbladder disease, and potential worsening of diabetic retinopathy, particularly with rapid improvement in glucose control

DOI: 10.1016/j.drudis.2025.104333, Pratt, E., Ma, X., Liu, R., et al

Yes, the $99 Precision Peptide Genetic Test available after your first month of treatment qualifies as an HSA and FSA eligible expense because it provides diagnostic information to optimize your personalized GLP-1 therapy based on genetic variants in 14 peptide pathways

however, not all do

Even if the results for others seem appealing, theres a lot to take into consideration